Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasugrel vs Clopidogrel in High Platelet Reactivity Post-PCI
NCT00910299Phase 2Terminated
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2009
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of prasugrel in coronary artery disease (CAD), sponsored by Eli Lilly and Company. Started Jul 2009; status: terminated.
02
Drugs
prasugrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00910299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00910299.